 | Up a level |
2017
De Castro, Gilberto, Jr., Tan, Daniel Shao-Weng, Crino, Lucio, Wu, Yi Long, Paz-Ares, Luis, Wolf, Juergen, Geater, Sarayut, Orlov, Sergey, Cortinovis, Diego, Yu, Chong-Jen, Hochmair, Maximilian, Cortot, Alexis, Tsai, Chun-Ming, Moro-Sibilot, Denis, Campelo, Rosario Garcia, Branle, Fabrice, Sen, Paramita, Mcculloch, Tracey and Soria, Jean-Charles (2017). First-line Ceritinib Versus Chemotherapy in Patients with ALK-rearranged (ALK plus ) NSCLC: A Randomized, Phase 3 Study (ASCEND-4). J. Thorac. Oncol., 12 (1). S. S7 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
Soria, Jean-Charles, Tan, Daniel S. W., Chiari, Rita, Wu, Yi-Long 
ORCID: 0000-0002-3611-0258, Paz-Ares, Luis, Wolf, Juergen, Geater, Sarayut L., Orlov, Sergey ORCID: 0000-0001-6080-8042, Cortinovis, Diego, Yu, Chong-Jen ORCID: 0000-0001-5664-9392, Hochmair, Maximillian, Cortot, Alexis B., Tsai, Chun-Ming, Moro-Sibilot, Denis, Campelo, Rosario G., McCulloch, Tracey, Sen, Paramita, Dugan, Margaret, Pantano, Serafino, Branle, Fabrice, Massacesi, Cristian and de Castro, Gilberto, Jr.
(2017).
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.
Lancet, 389 (10072).
S. 917 - 930.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Tan, Daniel Shao-Weng, Soria, Jean-Charles, De Castro, Gilberto, Jr., Wu, Yi Long, Paz-Ares, Luis, Wolf, Juergen, Geater, Sarayut, Orlov, Sergey, Cortinovis, Diego, Yu, Chong-Jen, Hochmair, Maximilian, Cortot, Alexis, Tsai, Chun-Ming, Moro-Sibilot, Denis, Campelo, Rosario Garcia, Branle, Fabrice, Sen, Paramita, Struebbe, Gero, Mcculloch, Tracey and Crino, Lucio (2017). PROs With Ceritinib Versus Chemotherapy in Patients With Previously Untreated ALK-rearranged Nonsquamous NSCLC (ASCEND-4). J. Thorac. Oncol., 12 (1). S. S1176 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
2014
Shaw, Alice, Mehra, Ranee, Tan, Daniel S. W., Felip, Enriqueta, Chow, Laura Q. M., Camidge, D. Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando ORCID: 0000-0003-1709-9492, Geraldes, Margarida, Sen, Paramita, Boral, Anthony J., Yovine, Alejandro and Kim, Dong-Wan
(2014).
CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK plus ) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL.
Neuro-Oncology, 16.
CARY:
OXFORD UNIV PRESS INC.
ISSN 1523-5866